No abstract

respiratory syndrome coronavirus 2, but it can also cause thromboembolic complications through coagulopathy. 3,4 In particular, several studies reported a high prevalence of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT) in hospi-T he coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019, and has become a huge threat worldwide as a pandemic. 1,2 The main pathophysiology of COVID-19 is a respiratory infectious disease caused by the severe acute

We have developed an over 60-inch size Moth-eye anti-reflection surface, which has original shaped nanostructures. The minimum reflectance was 0.02% and the average was less than 0.04% with little wavelength dependence. Moreover an anti-glare function was added. The 60-inch LCD applied AG Moth-eye surface had an excellent visibility in bright environments.

No abstract

No abstract

Background Simultaneous cerebral and myocardial infarction is called cardiocerebral infarction (CCI), and is rarely encountered. Because of the narrow time window and complex pathophysiology, CCI is challenging to immediately diagnose and treat. Case presentation A 73-year-old woman suddenly developed right hemiplegia and severe aphasia. Twelve-lead electrocardiography showed tachycardic atrial fibrillation without any significant ST-T change. Magnetic resonance imaging revealed a proximal middle cerebral artery occlusion. She was immediately treated with alteplase at the dosage approved for ischemic stroke followed by mechanical thrombectomy as bridging therapy, and complete recanalization was achieved. Aphasia improved and she began to complain of chest pain, and reported that she had experienced chest discomfort just prior to right limb weakness. Coronary angiography showed a partial filling defect in the right coronary artery with rapid and adequate distal flow, for which percutaneous coronary intervention was not required. Alteplase was suggested to have effectively resolved the coronary emboli. The occlusions of the cerebral and coronary arteries were assumed to have occurred nearly simultaneously and cardiogenic embolism due to atrial fibrillation was considered as the most likely etiology. Conclusions As seen in the present case, CCI may benefit from immediate treatment with intravenous tissue plasminogen activator (IV-tPA). Although which of percutaneous coronary intervention or cerebral thrombectomy should be performed first remains unclear, we must decide whether to rescue the brain or heart first in each patient within a limited window of time. This dilemma has recently become evident in this era with mechanical thrombectomy strongly established as an effective intervention for acute ischemic stroke. Close cooperation between stroke physicians and cardiologists is becoming more important.

Background:The number of patients on maintenance hemodialysis (HD) diagnosed with sarcopenia has been increasing through as individuals age. Recent focus is on the condition termed, "dynapenia," which reduces only muscle function, as opposed to sarcopenia, which reduces both muscle mass and function. However, the association between dynapenia and cardio-cerebrovascular (CV) events in patients undergoing HD is largely unknown. Objectives:The purpose of this study was to evaluate whether sarcopenia and dynapenia are associated with the onset of CV events in patients undergoing HD. Methods:We retrospectively analyzed 342 patients undergoing HD between January and December 2018. Patients who underwent HD thrice per week for > 3 months were included in the analysis. We adopted the Asian Working Group on Sarcopenia criteria for the diagnosis of sarcopenia and dynapenia.Results: In this study, 244 patients undergoing HD were enrolled. The prevalence of sarcopenia was 38.5%. Sarcopenia was determined to be an independent contributor to CV events in patients undergoing HD. To investigate the clinical relevance of dynapenia in patients with HD, patients without sarcopenia were further divided into dynapenia and non-dynapenia groups. Among 150 patients without sarcopenia, 46 were diagnosed with

It is known that particle size obtained from Brownian motion of a particle is called the diffusion coefficient equivalent size (DCES) and is close to the geometric size independent of the physical properties of a particle. In this paper, it is described that real time measurement of the particle size and particle number concentration by observing the Brownian motion of the particles from which the influence of the flow field has been eliminated by the instrument combining the flow particle tracking (FPT) method and the L-shaped flow cell. Furthermore, we realized in evaluating the refractive index, which is the physical property information of the particles, from the DCES, the Rayleigh scattering equation and the light scattering intensity of particle that physical properties are known. In this paper, we also discuss that improvement of particle size accuracy and refractive index accuracy in the measurement of DCES. Index Terms-Brownian motion, diffusion coefficient equivalent size (DCES), flow particle tracking (FPT) method, physical properties of a particle, refractive index.